Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (16) 16
life sciences & biomedicine (15) 15
humans (12) 12
neurosciences (7) 7
aged (6) 6
alzheimer's disease (6) 6
cerebrospinal fluid (6) 6
female (6) 6
male (6) 6
middle aged (6) 6
neurology (6) 6
neurosciences & neurology (6) 6
aged, 80 and over (5) 5
alzheimer disease - cerebrospinal fluid (5) 5
alzheimer disease - diagnosis (5) 5
amyloid beta-peptides - cerebrospinal fluid (5) 5
clinical neurology (5) 5
mass spectrometry (5) 5
mycophenolic acid - pharmacokinetics (5) 5
peptide fragments - cerebrospinal fluid (5) 5
adult (4) 4
immunoassay (4) 4
immunosuppressive agents - pharmacokinetics (4) 4
reproducibility of results (4) 4
alzheimer’s disease (3) 3
biomarkers (3) 3
biomarkers - cerebrospinal fluid (3) 3
calibration (3) 3
medical laboratory technology (3) 3
methods (3) 3
mycophenolic acid - adverse effects (3) 3
mycophenolic acid - analogs & derivatives (3) 3
mycophenolic acid - therapeutic use (3) 3
neuroimaging (3) 3
peptides (3) 3
pharmacokinetics (3) 3
plasma (3) 3
tandem mass spectrometry - methods (3) 3
transplantation (3) 3
adolescent (2) 2
alzheimer disease - blood (2) 2
amyloid beta-peptides - blood (2) 2
analysis (2) 2
area under curve (2) 2
biological and medical sciences (2) 2
building (2) 2
catalysis (2) 2
ceilings (2) 2
chemistry (2) 2
chemistry, physical (2) 2
child (2) 2
child, preschool (2) 2
cognitive dysfunction - cerebrospinal fluid (2) 2
csf biomarkers (2) 2
diagnosis (2) 2
diagnostic imaging (2) 2
environmental sciences (2) 2
environmental sciences & ecology (2) 2
equipment for shipping (2) 2
exact sciences and technology (2) 2
fixed constructions (2) 2
floors (2) 2
general and physical chemistry (2) 2
general building constructions (2) 2
glucuronides - metabolism (2) 2
immunosuppressive agents - adverse effects (2) 2
immunosuppressive agents - blood (2) 2
immunosuppressive agents - therapeutic use (2) 2
insulation or other protection of buildings (2) 2
iron catalyst (2) 2
longitudinal studies (2) 2
magnetic resonance imaging (2) 2
medical colleges (2) 2
medical sciences (2) 2
medicine & public health (2) 2
mycophenolic acid (2) 2
mycophenolic acid - administration & dosage (2) 2
mycophenolic acid - blood (2) 2
pathology (2) 2
performing operations (2) 2
pharmacology (2) 2
pharmacology & pharmacy (2) 2
pharmacology. drug treatments (2) 2
physical sciences (2) 2
positron emission tomography (2) 2
predictive value of tests (2) 2
prognosis (2) 2
prospective studies (2) 2
regression analysis (2) 2
related equipment (2) 2
roofs (2) 2
ships or other waterborne vessels (2) 2
surgery (2) 2
tacrolimus - administration & dosage (2) 2
tau proteins - cerebrospinal fluid (2) 2
theory of reactions, general kinetics. catalysis. nomenclature, chemical documentation, computer chemistry (2) 2
toxicology (2) 2
transporting (2) 2
walls, e.g. partitions (2) 2
young adult (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI
by Shaw, Leslie M and Vanderstichele, Hugo and Knapik-Czajka, Malgorzata and Figurski, Michal and Coart, Els and Blennow, Kaj and Soares, Holly and Simon, Adam J and Lewczuk, Piotr and Dean, Robert A and Siemers, Eric and Potter, William and Lee, Virginia M.-Y and Trojanowski, John Q and Alzheimer's Dis Neuroimaging Initi and Alzheimer's Disease Neuroimaging Initiative and the Alzheimer’s Disease Neuroimaging Initiative and Sahlgrenska akademin and Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi and Göteborgs universitet and Gothenburg University and Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry and Sahlgrenska Academy
Acta neuropathologica, ISSN 0001-6322, 5/2011, Volume 121, Issue 5, pp. 597 - 609
Interlaboratory study | Pathology | Neurosciences | Medicine & Public Health | Cerebrospinal fluid | p-tau 181 | Amyloid-β1-42 | Total tau | Alzheimer’s Disease Neuroimaging Initiative | Mixed-effects modeling | Alzheimer's Disease Neuroimaging Initiative | p-tau | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Predictive Value of Tests | Reproducibility of Results | Peptide Fragments - cerebrospinal fluid | Prognosis | Humans | Middle Aged | tau Proteins - cerebrospinal fluid | Cognitive Dysfunction - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Alzheimer Disease - diagnosis | Alzheimer Disease - mortality | Sensitivity and Specificity | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Aged | Cognitive Dysfunction - diagnosis | Biomarkers - cerebrospinal fluid | Cognitive Dysfunction - mortality | Index Medicus | p-tau181 | Psykiatri | Psychiatry
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Qualification of a surrogate matrix-based absolute quantification method for amyloid-β₄₂ in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometry
by Korecka, Magdalena
Journal of Alzheimer's disease, ISSN 1387-2877, 2014, Volume 41, Issue 2, pp. 441 - 451
mass spectrometry | Alzheimer's disease | cerebrospinal fluid | amyloid-$\beta_{42} | Immunoassay | Peptide Fragments - cerebrospinal fluid | Guanidine - chemistry | Humans | Middle Aged | Linear Models | Calibration | Alzheimer Disease - cerebrospinal fluid | Alzheimer Disease - diagnosis | Acetonitriles - chemistry | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Chromatography, Liquid | Adult | ROC Curve | Aged | Biomarkers - cerebrospinal fluid | Tandem Mass Spectrometry - methods | Quality Control | Index Medicus | Alzheimer’s disease | amyloid-β42
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Web‐based requisitioning, tracking and laboratory result reporting system for clinical trials using a central laboratory
by Figurski, Michal J and Berlas, Shaila and Korecka, Magdalena and Foroud, Tatiana M and Galasko, Doug R and Shaw, Leslie M
Alzheimer's & dementia, ISSN 1552-5260, 12/2020, Volume 16, p. n/a
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text P3‐232: VALIDATION STUDIES OF NEUROFILAMENT LIGHT AND Aβ‐40 AND Aβ‐42 ASSAYS IN HUMAN PLASMA USING THE SIMOA PLATFORM
by Waligorska, Teresa and Figurski, Michal J and Jeromin, Andreas and Chen-Plotkin, Alice and Trojanowski, John Q and Shaw, Leslie M
Alzheimer's & dementia, ISSN 1552-5260, 07/2019, Volume 15, pp. P1022 - P1022
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text P1‐265: STANDARDIZATION OF AMYLOID BETA 42 IN‐HOUSE CALIBRATORS FOR A REFERENCE LC‐MS‐MS METHOD FOR ANALYSIS OF AMYLOID BETA 42 IN HUMAN CSF, USING THREE AVAILABLE CERTIFIED REFERENCE MATERIALS
by Korecka, Magdalena and Figurski, Michal J and Trojanowski, John Q and Shaw, Leslie M
Alzheimer's & dementia, ISSN 1552-5260, 07/2019, Volume 15, pp. P341 - P341
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text P2‐091: ASSAY PERFORMANCE MONITORING FOR AD BIOMARKERS USING POOLED CEREBROSPINAL FLUID
by Figurski, Michal J and Waligorska, Teresa and Korecka, Magdalena and Brylska, Magdalena and Alexander, Jacob and Shaw, Leslie M
Alzheimer's & dementia, ISSN 1552-5260, 07/2018, Volume 14, Issue 7S_Part_13, pp. P702 - P703
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text DERIVING A CUT-OFF FOR THE ELECSYS® β-AMYLOID (1–42) IMMUNOASSAY FOR USE IN CLINICAL TRIALS SUPPORTED BY ELI LILLY FOR PATIENTS WITH CLINICALLY DEFINED ALZHEIMER’S DISEASE (AD)
by Shaw, Leslie M and Waligorska, Teresa and Fields, Leona and Korecka, Magdalena and Figurski, Michal J and Trojanowski, John Q and Eichenlaub, Udo and Wahl, Simone and Quan, Marian and Lachno, David Richard and Talbot, Jayne A and Andersen, Scott W and Siemers, Eric R and Dean, Robert A
Alzheimer's & dementia, ISSN 1552-5260, 07/2017, Volume 13, Issue 7, pp. P1317 - P1318
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI
by Toledo, Jon B and Vanderstichele, Hugo and Figurski, Michal and Aisen, Paul S and Petersen, Ronald C and Weiner, Michael W and Jack Jr, Clifford R and Jagust, William and Decarli, Charles and Toga, Arthur W and Toledo, Estefanía and Xie, Sharon X and Lee, Virginia M.-Y and Trojanowski, John Q and Shaw, Leslie M and Alzheimer’s Disease Neuroimaging Initiative
Acta neuropathologica, ISSN 0001-6322, 10/2011, Volume 122, Issue 4, pp. 401 - 413
Pathology | Neurosciences | Biomarker | Prognosis | Medicine & Public Health | Alzheimer disease | Amyloid beta-peptides | Diagnosis | Cerebrospinal fluid | PET | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neuroimaging - methods | Brain Infarction - diagnosis | Prospective Studies | Humans | Middle Aged | Brain Infarction - metabolism | Male | Biomarkers - blood | Amyloid beta-Peptides - blood | Alzheimer Disease - diagnosis | Magnetic Resonance Imaging | Brain Infarction - blood | Alzheimer Disease - metabolism | Aged, 80 and over | Female | Aged | Longitudinal Studies | Alzheimer Disease - blood | Cohort Studies | Index Medicus | Neurodegenerative diseases | biomarkers | Cognitive ability | beta -Amyloid | Magnetic resonance imaging | Tau protein | Classification | Infarction | Plasma levels | Alzheimer's disease | Positron emission tomography | Age
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text P1‐255: ANALYTICAL AND CLINICAL PERFORMANCE OF AMYLOID BETA PEPTIDES: MEASUREMENT IN CSF OF ADNI2 AND GO PARTICIPANTS BY A LC‐MS‐MS REFERENCE METHOD
by Korecka, Magdalena and Figurski, Michal J and Brylska, Magdalena and Alexander, Jackob and Trojanowski, John Q and Zetterberg, Henrik and Blennow, Kaj and Shaw, Leslie M
Alzheimer's & dementia, ISSN 1552-5260, 07/2018, Volume 14, Issue 7S_Part_7, pp. P378 - P378
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Derivation of cutoffs for the Elecsys® amyloid β (1–42) assay in Alzheimer's disease
by Shaw, Leslie M and Waligorska, Teresa and Fields, Leona and Korecka, Magdalena and Figurski, Michal and Trojanowski, John Q and Eichenlaub, Udo and Wahl, Simone and Quan, Marian and Pontecorvo, Michael J and Lachno, D. Richard and Talbot, Jayne A and Andersen, Scott W and Siemers, Eric R and Dean, Robert A
Alzheimer's & dementia : diagnosis, assessment & disease monitoring, ISSN 2352-8729, 2018, Volume 10, Issue 1, pp. 698 - 705
Immunoassay | Amyloid β | Biomarkers | Method comparison | Cutoff determination | Cerebrospinal fluid | Alzheimer's disease | Patient selection | Florbetapir F 18 imaging
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Prospective quality-control monitoring in the context of a clinical trial
by Figurski, Michal J and Waligórska, Teresa and Brylska, Magdalena and Korecka, Magdalena and Fields, Leona and Shah, Nirali and Pan, Sarah and Siemers, Eric R and Lachno, David R and Deckard, Deanilee and Dean, Robert A and Trojanowski, John Q and Shaw, Leslie M
Alzheimer's & dementia, ISSN 1552-5260, 2015, Volume 11, Issue 7, pp. P386 - P387
Neurology | Clinical trials
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text High-performance liquid chromatography-mass spectroscopy/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites
by Figurski, Michal J and Korecka, Magdalena and Fields, Leona and Waligórska, Teresa and Shaw, Leslie M
Therapeutic drug monitoring, ISSN 0163-4356, 12/2009, Volume 31, Issue 6, pp. 717 - 726
LC-MS/MS | Mycophenolic acid | Metabolites | Free concentration | Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Medical Laboratory Technology | Science & Technology | Biological and medical sciences | Pharmacology. Drug treatments | Medical sciences | Limit of Detection | Reproducibility of Results | Chromatography, High Pressure Liquid - methods | Microchemistry - methods | Humans | Immunosuppressive Agents - pharmacokinetics | Mycophenolic Acid - urine | Mycophenolic Acid - pharmacokinetics | Glucuronides - urine | Calibration | Glucuronides - blood | Immunosuppressive Agents - urine | Glucuronides - metabolism | Immunosuppressive Agents - blood | Mycophenolic Acid - analogs & derivatives | Spectrometry, Mass, Electrospray Ionization | Time Factors | Mycophenolic Acid - blood | Analytic Sample Preparation Methods | Tandem Mass Spectrometry - methods | Acylation | Plasma | Immunotherapy | Pharmacology | Drug therapy | Mass spectrometry | Chromatography | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text P1‐119: Prospective quality‐control monitoring in the context of a clinical trial
by Figurski, Michal J and Waligórska, Teresa and Brylska, Magdalena and Korecka, Magdalena and Fields, Leona and Shah, Nirali and Pan, Sarah and Siemers, Eric R and Lachno, David R and Deckard, Deanilee and Dean, Robert A and Trojanowski, John Q and Shaw, Leslie M
Alzheimer's & dementia, ISSN 1552-5260, 07/2015, Volume 11, Issue 7S_Part_8, pp. P386 - P387
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Detection of Alzheimer Disease Pathology in Patients Using Biochemical Biomarkers: Prospects and Challenges for Use in Clinical Practice
by Shaw, Leslie M and Korecka, Magdalena and Figurski, Michal and Toledo, Jon and Irwin, David and Hee Kang, Ju and Trojanowski, John Q
The journal of applied laboratory medicine, ISSN 2576-9456, 01/2020, Volume 5, Issue 1, pp. 183 - 193
Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Improved protocol for measurement of plasma β-amyloid in longitudinal evaluation of Alzheimer’s Disease Neuroimaging Initiative study patients
by Figurski, Michal J and Waligórska, Teresa and Toledo, Jon and Vanderstichele, Hugo and Korecka, Magdalena and Lee, Virginia M.Y and Trojanowski, John Q and Shaw, Leslie M and Alzheimer’s Disease Neuroimaging Initiative and Alzheimer's Dis Neuroimaging Initi
Alzheimer's & dementia, ISSN 1552-5260, 07/2012, Volume 8, Issue 4, pp. 250 - 260
Neurology | Plasma | xMAP immunoassay | Longitudinal | Robotic pipetting | ADNI study subjects | β-amyloid | β‐amyloid | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neuroimaging | Immunoassay | Peptide Fragments - cerebrospinal fluid | Humans | Male | Statistics as Topic | Alzheimer Disease - cerebrospinal fluid | Amyloid beta-Peptides - blood | Alzheimer Disease - diagnosis | Likelihood Functions | Peptide Fragments - blood | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Female | Aged | Longitudinal Studies | Alzheimer Disease - blood | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text The Alzheimer’s Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans
by Kang, Ju-Hee and Korecka, Magdalena and Figurski, Michal J and Toledo, Jon B and Blennow, Kaj and Zetterberg, Henrik and Waligorska, Teresa and Brylska, Magdalena and Fields, Leona and Shah, Nirali and Soares, Holly and Dean, Robert A and Vanderstichele, Hugo and Petersen, Ronald C and Aisen, Paul S and Saykin, Andrew J and Weiner, Michael W and Trojanowski, John Q and Shaw, Leslie M and Alzheimer's Disease Neuroimaging Initiative and Alzheimer's Dis Neuroimaging Initi and Sahlgrenska akademin and Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi and Göteborgs universitet and Gothenburg University and Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry and Sahlgrenska Academy
Alzheimer's & dementia, ISSN 1552-5260, 07/2015, Volume 11, Issue 7, pp. 772 - 791
Neurology | ADNI | Plasma | Immunoassay | Mild cognitive impairment | Biomarkers | Tau | Cerebrospinal fluid | Alzheimer's disease | Disease-modifying therapy | Aβ1–42 | Disease‐modifying therapy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Alzheimer Disease - diagnosis | Databases, Bibliographic - statistics & numerical data | Peptide Fragments - cerebrospinal fluid | Humans | Amyloid beta-Peptides - cerebrospinal fluid | tau Proteins - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Medical colleges | Development and progression | Neurosciences | Diagnostic imaging | Index Medicus | Alzheimer’s disease | Neurologi | CSF BIOMARKERS | APOLIPOPROTEIN-E GENOTYPE | TANDEM MASS-SPECTROMETRY | CEREBROSPINAL-FLUID BIOMARKERS | AMYLOID-BETA | A-BETA | DIAGNOSTIC GUIDELINES | GENOME-WIDE ASSOCIATION
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights